Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 1—January 2020

Effect of Pediatric Influenza Vaccination on Antibiotic Resistance, England and Wales

Chungman Chae1, Nicholas G. Davies1Comments to Author , Mark Jit, and Katherine E. Atkins
Author affiliations: London School of Hygiene and Tropical Medicine, London, UK (C. Chae, N.G. Davies, M. Jit, K.E. Atkins); Public Health England, London (M. Jit); University of Edinburgh, Scotland, UK (K.E. Atkins)

Main Article

Table 2

Projected effect of pediatric LAIV on adverse health outcomes associated with antibiotic resistance, England and Wales*

Outcome Estimate for 2015,
England and Wales Projected reduction in outcome resulting from LAIV, mean (95% HDI)
DALYs 46,039 642 (450–842)
Cases 47,080 432 (303–566)
Deaths 1,930 22 (16–29)

*DALYs, disability-adjusted life years; HDI, highest density interval; LAIV, live attenuated influenza vaccine.

Main Article

1These authors contributed equally to this article.

Page created: December 18, 2019
Page updated: December 18, 2019
Page reviewed: December 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.